Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 89 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT05744921
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
- Toronto General Hospital Toronto, Ontario, Canada
- Hospital Pablo Tobon Uribe Medellín, Antioquia, Colombia
- Semmelweis University/Semmelweis Egyetem Budapest, Hungary
- Amrita Institute of Medical Sciences (AIMS) and Research Centre Aims Kochi, Kerala, India
NCT07154745
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
- Hospital das Clinicas da FMRP USP Ribeirão Preto, São Paulo, Brazil
- Faculdade de Medicina do ABC Santo André, São Paulo, Brazil
- CISSS-CA Lévis, Quebec, Canada
- Universita Cattolica del Sacro Cuore - Policlinico Universitario A. Gemelli Rome, Lazio, Italy
NCT05776472
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
- Liverpool Hospital Liverpool, New South Wales, Australia
- Calvary Mater Newcastle Waratah, New South Wales, Australia
- Sunshine Coast University Hospital Birtinya, Queensland, Australia
- Canberra Hospital Garran, Australia
NCT07416162
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +23 more
- Locations
-
- Novartis Investigative Site Jeollanam, South Korea
- Novartis Investigative Site Seoul, South Korea
- Novartis Investigative Site Seoul, South Korea
NCT06412497
- Conditions
- Acquired Amegakaryocytic Thrombocytopenia, Acquired Pure Red Cell Aplasia, Acquired amegakaryocytic thrombocytopenia, +11 more
- Locations
-
- University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States
NCT06931691
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
- Novartis Investigative Site Hefei, Anhui, China
- Novartis Investigative Site Guangzhou, Guangdong, China
- Novartis Investigative Site Guangzhou, Guangdong, China
- Novartis Investigative Site Shijiazhuang, Hebei, China
Study of Safety and Efficacy of HS-10542 in Patients With Paroxysmal Nocturnal Hemoglobinuria
NCT07470762
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
- The First Affiliated Hospital,Zhejiang University School of Medicine Hangzhou, Zhejiang, China
NCT06449001
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +10 more
- Locations
-
- Research Site Saskatoon, Saskatchewan, Canada
- Research Site Paris, France
- Research Site Leeds, United Kingdom
- Research Site London, United Kingdom
Home Reported Outcomes in PNH
NCT06411626
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
- Novartis Investigative Site East Hanover, New Jersey, United States
NCT06932471
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
- Peking Union Medical College Hospital (PUMCH). Beijing, Beijing Municipality, China
Global PNH Patient Registry
NCT05755867
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
- Aplastic Anemia and MDS International Foundation Bethesda, Maryland, United States
Long-term Safety and Tolerability of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria
NCT06745622
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
- The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China
NCT06524726
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +16 more
- Locations
-
- International PNH Interest Group Altamonte Springs, Florida, United States
A Multicenter, Open-label Study Evaluating the Long-term Safety and Efficacy of XH-S003 Capsules in Patients With Paroxysmal Nocturnal Hemoglobinuria
NCT07657052
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
- TianJin Medical University General Hospital Tianjin, Jinan, China
Study of NM8074 in Adult PNH Patients With Inadequate Response to Soliris
NCT05646563
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
Not specified
Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
NCT07266155
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
- The First Affiliated Hospital of Nanjing Medical University Nanjing, China
A Phase III Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients
NCT07177859
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
A Long-term Efficacy and Safety of NTQ5082 Capsules
NCT07177872
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences , Tianjin, Tianjin Municipality, China
Study of Efficacy and Safety of NM8074 in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy
NCT05646524
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
Not specified
To Evaluate the Effect of Single Oral Dose of MY008211A Tablets on QTc Interval in Healthy Subjects
NCT06543459
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
- Peking University Third Hospital Beijing, Beijing Municipality, China